Brief: Alembic Pharma Q1 Consol Profit 1.73 Billion Rupees
04/08/2026 09:44
BRIEF-Alembic Pharma Q1 Consol Profit 1.73 Billion Rupees Aug 4 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS:
ALEMBIC PHARMA Q1 CONSOL PROFIT 1.73 BILLION RUPEES
ALEMBIC PHARMA Q1 CONSOL REVENUE FROM OPERATIONS 21.5 BILLION RUPEES
Source text: [ID:]
Further company coverage: ALEM.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand